These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 8354078)

  • 1. Pediatric immunizations.
    Edwards KM
    Curr Probl Pediatr; 1993; 23(5):186-209. PubMed ID: 8354078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vaccination in childhood].
    Spiess H
    Dtsch Med Wochenschr; 1972 Jan; 97(4):125-31. PubMed ID: 4550326
    [No Abstract]   [Full Text] [Related]  

  • 3. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
    Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
    Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization against infectious disease.
    Olshin IJ
    Compr Ther; 1984 Jun; 10(6):13-9. PubMed ID: 6734129
    [No Abstract]   [Full Text] [Related]  

  • 5. Have your young pediatric patients been immunized properly?
    Waldman HB
    ASDC J Dent Child; 1998; 65(2):107-10. PubMed ID: 9617450
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
    Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
    Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of antibodies in 4-8 year old Austrian children after vaccination with hexavalent DTaP-HBV-IPV/Hib and MMR vaccines.
    Paulke-Korinek M; Fischmeister G; Grac A; Rendi-Wagner P; Kundi M; Mohsenzadeh-Rabbani A; Moritz K; Fenninger B; Jarisch R; Jasinska J; Holzmann H; Wiedermann U; Kollaritsch H
    Vaccine; 2011 Jul; 29(32):5130-6. PubMed ID: 21624412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keeping immunizations up to date.
    Reece RM
    Am Fam Physician; 1974 Mar; 9(3):119-25. PubMed ID: 4855929
    [No Abstract]   [Full Text] [Related]  

  • 9. Vaccination update. Diphtheria, tetanus, pertussis, mumps, rubella, measles.
    Vetter RT; Johnson GM
    Postgrad Med; 1995 Oct; 98(4):133-7, 141-2, 144-5 passim. PubMed ID: 7567714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decision making for routine measles/MMR and whooping cough immunisation.
    Nicoll A; Jenkinson D
    BMJ; 1988 Aug; 297(6645):405-7. PubMed ID: 3408985
    [No Abstract]   [Full Text] [Related]  

  • 11. From the Centers for Disease Control and Prevention. Reported vaccine-preventable diseases--United States, 1993, and the childhood immunization initiative.
    JAMA; 1994 Mar; 271(9):651-2. PubMed ID: 8309018
    [No Abstract]   [Full Text] [Related]  

  • 12. The control of diphtheria, tetanus, poliomyelitis, measles, rubella and mumps.
    Dudgeon JA
    Practitioner; 1975 Sep; 215(1287):299-309. PubMed ID: 1101251
    [No Abstract]   [Full Text] [Related]  

  • 13. Adult immunizations: update on recommendations.
    Pham H; Geraci SA; Burton MJ;
    Am J Med; 2011 Aug; 124(8):698-701. PubMed ID: 21658665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reported vaccine-preventable diseases--United States, 1993, and the childhood immunization initiative.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Feb; 43(4):57-60. PubMed ID: 8295625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symposium on pertussis immunization, in honor of Dr. Pearl L. Kendrick in her eightieth year: current status of combined vaccines.
    Brown GC
    Health Lab Sci; 1971 Oct; 8(4):210-4. PubMed ID: 4940069
    [No Abstract]   [Full Text] [Related]  

  • 16. The performance of the expanded programme on immunization in a rural area of Mozambique.
    Lanaspa M; Balcells R; Sacoor C; Nhama A; Aponte JJ; Bassat Q
    Acta Trop; 2015 Sep; 149():262-6. PubMed ID: 26095045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
    Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A
    Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B; Wald E; Guerra N; Byers C
    Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vaccination of children in 1996].
    Levy J
    Rev Med Brux; 1996 Sep; 17(4):250-2. PubMed ID: 8927855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB).
    Bar-On ES; Goldberg E; Fraser A; Vidal L; Hellmann S; Leibovici L
    Cochrane Database Syst Rev; 2009 Jul; (3):CD005530. PubMed ID: 19588375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.